Search

everythinglearnresearchcommunity

for

Search:↓

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

A systematic approach is crucial for managing hair loss in women.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

Stem cell serum effectively treated hair loss caused by COVID-19.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Monilethrix is a rare, inherited condition causing fragile hair and hair loss, with no cure but some treatments may help.

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

Women with thinning hair have thinner hair strands than women without hair loss.

Mother and son diagnosed with a rare genetic hair loss condition with no effective treatment.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Wolvit® (biotin 5 mg) is effective and safe for treating hair loss and scalp conditions in women.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Misdiagnosis led to permanent hair loss, stressing the need for proper scalp tests.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Topical eye β-blockers may cause hair loss.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Senescent alopecia is a type of hair loss that occurs after age 50, not caused by genetics, and involves a gradual thinning of hair without significant inflammation.

The document says that Androgenetic alopecia, a common hair loss condition, affects women less often and usually less severely, but early diagnosis and treatment are important.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.